Observational Study of BIS in Hemodialysis Patients

UnknownOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

November 8, 2022

Study Completion Date

September 30, 2023

Conditions
Kidney Failure, ChronicRenal Failure ChronicHemodialysis
Interventions
DEVICE

Bioimpedance spectroscopy (BIS) measurement, SOZO device

All patients enrolled in this study will undergo BIS measurement before and after 12 hemodialysis sessions (pre-dialysis and post-dialysis BIS measurements for each session). Measurements are not provided to treating physicians and are not used to guide clinical decisions; i.e., BIS measurements are collected for observational purposes only.

Trial Locations (2)

92111

Balboa Research - Kearny Mesa, San Diego

92127

Balboa Research - Rancho Bernardo, San Diego

All Listed Sponsors
collaborator

California Institute of Renal Research

OTHER

collaborator

Frenova Renal Research

OTHER

lead

ImpediMed Limited

INDUSTRY

NCT05381961 - Observational Study of BIS in Hemodialysis Patients | Biotech Hunter | Biotech Hunter